359 related articles for article (PubMed ID: 23982206)
21. Regulation of nuclear factor kappaB in the hippocampus by group I metabotropic glutamate receptors.
O'Riordan KJ; Huang IC; Pizzi M; Spano P; Boroni F; Egli R; Desai P; Fitch O; Malone L; Ahn HJ; Liou HC; Sweatt JD; Levenson JM
J Neurosci; 2006 May; 26(18):4870-9. PubMed ID: 16672661
[TBL] [Abstract][Full Text] [Related]
22. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
[TBL] [Abstract][Full Text] [Related]
23. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
[TBL] [Abstract][Full Text] [Related]
24. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation.
Meyer CF; Wang X; Chang C; Templeton D; Tan TH
J Biol Chem; 1996 Apr; 271(15):8971-6. PubMed ID: 8621542
[TBL] [Abstract][Full Text] [Related]
25. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
Nolz JC; Fernandez-Zapico ME; Billadeau DD
J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
[TBL] [Abstract][Full Text] [Related]
27. Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation.
Garbati MR; Gilmore TD
Gene Expr; 2008; 14(4):195-205. PubMed ID: 19110719
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide repression of NF-κB target genes by transcription factor MIBP1 and its modulation by O-linked β-N-acetylglucosamine (O-GlcNAc) transferase.
Iwashita Y; Fukuchi N; Waki M; Hayashi K; Tahira T
J Biol Chem; 2012 Mar; 287(13):9887-9900. PubMed ID: 22294689
[TBL] [Abstract][Full Text] [Related]
29. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
[TBL] [Abstract][Full Text] [Related]
30. cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain.
Fognani C; Rondi R; Romano A; Blasi F
Oncogene; 2000 Apr; 19(18):2224-32. PubMed ID: 10822372
[TBL] [Abstract][Full Text] [Related]
31. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.
Gerondakis S; Strasser A; Metcalf D; Grigoriadis G; Scheerlinck JY; Grumont RJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3405-9. PubMed ID: 8622948
[TBL] [Abstract][Full Text] [Related]
32. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA
J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773
[TBL] [Abstract][Full Text] [Related]
33. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
Rao S; Gerondakis S; Woltring D; Shannon MF
J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
[TBL] [Abstract][Full Text] [Related]
34. A novel NF-kappa B/Rel site in intron 1 cooperates with proximal promoter elements to mediate TNF-alpha-induced transcription of the human polymeric Ig receptor.
Schjerven H; Brandtzaeg P; Johansen FE
J Immunol; 2001 Dec; 167(11):6412-20. PubMed ID: 11714807
[TBL] [Abstract][Full Text] [Related]
35. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages.
Sanjabi S; Hoffmann A; Liou HC; Baltimore D; Smale ST
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12705-10. PubMed ID: 11058167
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
González E; Punzón C; González M; Fresno M
J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
[TBL] [Abstract][Full Text] [Related]
37. Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice.
Ramakrishnan P; Yui MA; Tomalka JA; Majumdar D; Parameswaran R; Baltimore D
Diabetes; 2016 Aug; 65(8):2367-79. PubMed ID: 27217485
[TBL] [Abstract][Full Text] [Related]
38. PACT-mediated PKR activation acts as a hyperosmotic stress intensity sensor weakening osmoadaptation and enhancing inflammation.
Farabaugh KT; Krokowski D; Guan BJ; Gao Z; Gao XH; Wu J; Jobava R; Ray G; de Jesus TJ; Bianchi MG; Chukwurah E; Bussolati O; Kilberg M; Buchner DA; Sen GC; Cotton C; McDonald C; Longworth M; Ramakrishnan P; Hatzoglou M
Elife; 2020 Mar; 9():. PubMed ID: 32175843
[TBL] [Abstract][Full Text] [Related]
39. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IkappaBalpha degradation.
Aune TM; Mora AL; Kim S; Boothby M; Lichtman AH
J Immunol; 1999 May; 162(10):5805-12. PubMed ID: 10229814
[TBL] [Abstract][Full Text] [Related]
40. Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development.
Sivakumar V; Hammond KJ; Howells N; Pfeffer K; Weih F
J Exp Med; 2003 Jun; 197(12):1613-21. PubMed ID: 12810684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
